You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LXRX Buy Disclosure
Exton Michael · SEC Form 4 · Filed Nov 9, 2026
Buy
Calculated transaction value
$50K
Exton Michael Chief Executive Officer
LXRX
Transaction date
Nov 6, 2026
Public filing date
Nov 9, 2026
Filing lag
Filed 3 days later
LXRX daily price context
Close on/before transaction
$1.78
Nov 6, 2026
First close after public filing
$1.82
Nov 9, 2026
Return after filing · so far
+2.75%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 30,064 shares @ $1.66
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001062822-26-000130
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$50K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lexicon Pharmaceuticals, Inc. LXRX Current | Buy | Nov 6, 2026 | $50K |